HNO International, Inc 10-Q for FY2025 Q2
HNO International, Inc. (HNOI)
About this 10-Q
HNO International, Inc filed this 10-Q on June 23, 2025, covering the quarter ended April 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended April 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $43.71K
- compared with $0 a year earlier
- Net loss
- $470.07K
- compared with a net loss of $570.86K a year earlier
- Diluted EPS
- -$0.01
- compared with $0.00 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
For the quarterly period ended
OR
For the transition period from _________ to __________
Commission File Number:
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
|
(Address of principal executive offices) |
(Zip Code) | |
(
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate
by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ¨ | Accelerated filer | ¨ |
| x | Smaller reporting company | ||
| Emerging growth company |
| 1 |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨ No
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. As of June 20, 2025, the registrant had outstanding shares of Common Stock.
| 2 |
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed on March 20, 2025, and other filings we make with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.
The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with our audited financial statements and related notes thereto included elsewhere in this report, and in our Annual Report on Form 10-K filed on March 20, 2025.
| 3 |
HNO INTERNATIONAL, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED APRIL 30, 2025
TABLE OF CONTENTS
| PAGE | ||
| PART I | FINANCIAL INFORMATION | |
| Item 1. | Financial Statements (Unaudited) | 5 |
| Unaudited Condensed Balance Sheets as of April 30, 2025 and October 31, 2024 | 6 | |
| Unaudited Condensed Statements of Operations for the Three and Six Months Ended April 30, 2025 and April 30, 2024 | 7 | |
| Unaudited Condensed Statement of Stockholders’ Deficit for the Three and Six Months Ended April 30, 2025 and April 30, 2024 | 8 | |
| Unaudited Condensed Statements of Cash Flows for the Six Months Ended April 30, 2025 and April 30, 2024 | 9 | |
| Notes to Unaudited Condensed Financial Statements | 10 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 26 |
| Item 4. | Controls and Procedures | 26 |
| PART II | OTHER INFORMATION | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 27 |
| Item 5. | Other Information | 27 |
| Item 6. | Exhibits | 27 |
| Signatures | 28 |
| 4 |
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
| HNO INTERNATIONAL, INC. CONDENSED BALANCE SHEETS (Unaudited) | ||||||||
| April 30, | October 31, | |||||||
| 2025 | 2024 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivable | ||||||||
| Total Current Assets | ||||||||
| Non-Current Assets | ||||||||
| Property and equipment, net | ||||||||
| Long term asset, net | ||||||||
| Right-of-use asset | ||||||||
| Total Non-Current Assets | ||||||||
| TOTAL ASSETS | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued payroll | ||||||||
| Accrued interest payable | ||||||||
| Lease liability | ||||||||
| Payroll tax | ||||||||
| Advances, related party | ||||||||
| Convertible note payable, at fair value | ||||||||
| Customer deposits | ||||||||
| Notes payable, related party | ||||||||
| Total Current Liabilities | ||||||||
| Non-Current Liability | ||||||||
| Lease liability | ||||||||
| Long term notes payable, related party | ||||||||
| Total Non-Current Liability | ||||||||
| Total Liabilities | ||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||
| Preferred stock, par value $ per share; shares authorized | ||||||||
| Series A, par value $ per share; shares authorized; and shares issued and outstanding as of April 30, 2025 and October 31, 2024, respectively | ||||||||
| Series B, par value $ per share; shares authorized; and shares issued and outstanding as of April 30, 2025 and October 31, 2024, respectively | ||||||||
| Common stock, par value $ per share; shares authorized; and shares issued and outstanding as of April 30, 2025 and October 31, 2024, respectively | ||||||||
| Common stock payable | ||||||||
| Common stock subscription receivable | ( |
) | ( |
) | ||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( |
) | ( |
) | ||||
| Total Stockholders’ Deficit | ( |
) | ( |
) | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ | $ | ||||||
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||||||
| 5 |
| HNO INTERNATIONAL, INC. CONDENSED STATEMENTS OF OPERATIONS (Unaudited) | ||||||||||||||||
| For the Three Months Ended April 30, |
For the Six Months Ended April 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (As Restated) | (As Restated) | |||||||||||||||
| Revenue | $ | $ | $ | $ | ||||||||||||
| Cost of goods sold | ||||||||||||||||
| Gross Profit | ||||||||||||||||
| Operating expenses | ||||||||||||||||
| Advertising and marketing | ||||||||||||||||
| General and administrative expenses | ||||||||||||||||
| Depreciation and amortization | ||||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| Other Income (Expenses) | ||||||||||||||||
| Interest income | ||||||||||||||||
| Interest expense | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Loss on fair value of convertible note | ( |
) | ( |
) | ||||||||||||
| Loss on write-off of intangible asset | ( |
) | ( |
) | ||||||||||||
| Total Other (Expenses) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Loss from Operations | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
| Net Loss | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
| PER SHARE AMOUNTS | ||||||||||||||||
| Basic and diluted net loss per share |
$ | ) | $ | ) | $ | ) | $ | ) | ||||||||
| Weighted average number of common shares outstanding - basic and diluted | ||||||||||||||||
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||||||||||||||
| 6 |
| HNO INTERNATIONAL, INC. CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT For the three months and six months ended April 30, 2025 and 2024 (As Restated) (Unaudited) | ||||||||||||||||||||||||||||||||||||||||||||
| Series A Preferred Stock | Series B Preferred Stock | Common Stock | Stock | Share Subscription | Additional Paid-in | Accumulated | Total Stockholders' | |||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Payable | Receivable | Capital | Deficit | Deficit | ||||||||||||||||||||||||||||||||||
| Balance at October 31, 2023 (Restated) | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| Regulation A stock issuances | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Net loss for the three months ended January 31, 2024 | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
| Balance at January 31, 2024 (Restated) | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| Regulation A stock issuances | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Net loss for the three months ended April 30, 2024 | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
| Balance at April 30, 2024 (Restated) | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| Balance at October 31, 2024 | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| Regulation D stock issuances | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Shares cancelled as per exchange agreement | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Series B preferred stock issuances | — | $ | — | |||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Net loss for the three months ended January 31, 2025 | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
| Balance at January 31, 2025 | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| Regulation D stock issuances | — | — | ||||||||||||||||||||||||||||||||||||||||||
| Net loss for the three months ended April 30, 2025 | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
| Balance at April 30, 2025 | $ | $ | $ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||||||||||||||||||
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||||||||||||||||||||||||||||||||||||||||||
| 7 |
| HNO INTERNATIONAL, INC. CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) | ||||||||
| For the Six Months Ended April 30, | ||||||||
| 2025 | 2024 | |||||||
| (As Restated) | ||||||||
| Cash Flow from Operating Activities | ||||||||
| Net loss | $ | ( |
) | $ | ( |
) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Legal services provided in exchange for convertible note | ||||||||
| Loss on fair value of convertible note | ||||||||
| Loss on write-off of intangible asset | ||||||||
| Share based compensation | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Decrease in due from related party | ||||||||
| (Increase) in accounts receivable | ( |
) | ||||||
| Increase in accrued interest receivable | ( |
) | ||||||
| Increase/(Decrease) in accounts payable | ( |
) | ( |
) | ||||
| Increase/(Decrease) in accrued payroll | ( |
) | ||||||
| Increase/(Decrease) in accrued interest payable | ||||||||
| Increase in lease vendor payable | ||||||||
| Operating lease ROU assets and lease liabilities, net | ||||||||
| (Decrease) increase in payroll taxes | ( |
) | ||||||
| Net Cash Used in Operating Activities | ( |
) | ( |
) | ||||
| Cash Flows from Financing Activities | ||||||||
| Proceeds from related party advances | ||||||||
| Repayment of related party advances | ( |
) | ||||||
| Proceeds from security deposits | ||||||||
| Proceeds from sale of common stock subscription payable | ||||||||
| Proceeds from sale of common stock | ||||||||
| Net Cash Provided by Financing Activities | ||||||||
| Cash Flows from Investing Activities | ||||||||
| Purchase of property and equipment | ( |
) | ( |
) | ||||
| Purchase of long term asset | ( |
) | ||||||
| Net Cash Used in Investing Activities | ( |
) | ( |
) | ||||
| Net increase (decrease) in cash | ( |
) | ||||||
| Cash at beginning of period | ||||||||
| Cash at end of period | $ | $ | ||||||
| Supplemental Disclosure of Interest and Income Taxes Paid: | ||||||||
| Interest paid during the period | $ | $ | ||||||
| Income taxes paid during the period | $ | $ | ||||||
| Supplemental Disclosure for Non-Cash Investing and Financing Activities: | ||||||||
| Acquired property and equipment remaining in accounts payable | $ | $ | ||||||
| Common stock cancellation per share exchange agreement | $ | ( |
) | $ | ||||
| Series B preferred stock issuance per exchange agreement | $ | $ | ||||||
| Record right-to-use asset and lease liability per ASC 842 | $ | $ | ||||||
| Convertible note issued in exchange for legal services, recorded at fair value | $ | $ | ||||||
| The accompanying notes are an integral part of these condensed unaudited financial statements. | ||||||||
| 8 |
HNO INTERNATIONAL, INC.
NOTES TO CONDENSED UNAUDITED FINANCIAL STATEMENTS
APRIL 30, 2025
NOTE 1 – ORGANIZATION AND BASIS OF ACCOUNTING
Organization
HNO International, Inc. (the “Company”) was incorporated in the State of Nevada on May 2, 2005.
The Company specializes in the design, integration, and development of green hydrogen-based clean energy technologies. The Company is committed to providing scalable products that help businesses and communities decarbonize, reduce emissions, and cut operational costs. HNO stands for Hydrogen and Oxygen. The Company is at the forefront of developing innovative solutions, such as the Compact Hydrogen Refueling System (CHRS) and the Compact Hydrogen Production System (CHPS), which can be used to produce hydrogen for various applications including fuel cell electric vehicles, hydrogen internal combustion engines, heating and cooking applications. The CHPS is highly scalable, capable of producing 100-2,000 (or more) kilograms of hydrogen per day for commercial use in various applications. In addition, the Company develops energy systems that complement the zero-emissions EV infrastructure, reduce harmful emissions, and cut maintenance costs of commercial diesel fleets. By integrating components from leading industry partners, the Company aims to transition fossil fuels to cleaner alternatives and promote lower emissions.
NOTE 2 –FINANCIAL STATEMENT RESTATEMENT
In connection with the Company’s re-audit of its financial statements for the year ended October 31, 2023, the Company’s management, in consultation with its independent registered public accounting firm, identified corrections to the valuation of service stock issued during the year ended October 31, 2023, and the termination of the patent agreement entered into on January 24, 2023. The corrections made that impact the condensed financial statements for the quarter ended April 30, 2024, are summarized as follows:
- Stock Price Valuation Adjustment: The valuation of the stock price was adjusted from $ to $ and there was an increase in share-based compensation reflecting the revised valuation of stock.
- Equity Adjustments: There was a corresponding increase in additional paid-in capital and an adjustment in the accumulated deficit to reflect the revised stock valuation and related share-based compensation.
- Termination of Patent Purchase Agreement: On March 13, 2025,
the Company and Donald Owens mutually agreed to terminate the Patent Purchase Agreement as of January 24, 2023. As part of the termination,
the patents were returned to Mr. Owens, and the shares of Series A Preferred Stock were canceled. The $
- Reclassification of Expenses: Expenses incurred during the fiscal year ended October 31, 2023, and paid subsequently, have been reclassified to accounts payable as of October 31, 2023. This adjustment ensures that financial obligations are accurately reported in the period in which they were incurred.
- The restatement includes the initial recognition of right-of-use assets and corresponding lease liabilities on the balance sheet to properly reflect lease accounting in accordance with ASC 842.
These adjustments have been reflected in the restated financial statements for the quarter ended April 30, 2024.
Impact of the Restatement
The impact of the restatement on the financial statements for the affected period is presented below. In addition to the below, the related notes to the financial statements have also been adjusted as appropriate to reflect the impact of the restatement.
| 9 |
The impact of the restatement on the line items within the previously reported Condensed Unaudited Statement of Operations for the three and six months ended April 30, 2024, previously filed is as follows:
| Schedule of statement of operations | ||||||||||||
| Statement of Operations for the three months ended April 30, 2024 | As Previously Reported | Adjustment | As Restated | |||||||||
| Revenue | $ | $ | $ | |||||||||
| Cost of goods sold | $ | $ | $ | |||||||||
| Gross Profit | $ | $ | $ | |||||||||
| Operating expenses | ||||||||||||
| General and administrative expenses | $ | $ | $ | |||||||||
| Depreciation and amortization | $ | $ | $ | |||||||||
| Total Operating Expenses | $ | $ | $ | |||||||||
| Other Income (Expenses) | ||||||||||||
| Interest income | $ | $ | $ | |||||||||
| Interest expense | $ | ( |
) | $ | $ | ( |
) | |||||
| Total Other (Expenses) | $ | ( |
) | $ | $ | ( |
) | |||||
| Loss from Operations | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Net Loss | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| PER SHARE AMOUNTS | ||||||||||||
| Basic and diluted net loss per share |
$ | ) | $ | $ | ) | |||||||
| Weighted average number of common shares outstanding - basic and diluted | ||||||||||||
| Statement of Operations for the six months ended April 30, 2024 |
As Previously Reported | Adjustment | As Restated | |||||||||
| Revenue | $ | $ | $ | |||||||||
| Cost of goods sold | $ | $ | $ | |||||||||
| Gross Profit | $ | $ | $ | |||||||||
| Operating expenses | ||||||||||||
| General and administrative expenses | $ | $ | ( |
) | $ | |||||||
| Depreciation and amortization | $ | $ | $ | |||||||||
| Total Operating Expenses | $ | $ | ( |
) | $ | |||||||
| Other Income (Expenses) | ||||||||||||
| Interest income | $ | $ | $ | |||||||||
| Interest expense | $ | ( |
) | $ | $ | ( |
) | |||||
| Total Other (Expenses) | $ | ( |
) | $ | $ | ( |
) | |||||
| Loss from Operations | $ | ( |
) | $ | $ | ( |
) | |||||
| Net Loss | $ | ( |
) | $ | $ | ( |
) | |||||
| PER SHARE AMOUNTS | ||||||||||||
| Basic and diluted net loss per share |
$ | ) | $ | $ | ) | |||||||
| Weighted average number of common shares outstanding - basic and diluted |
| 10 |
The impact of the restatement on the line items within the previously reported Condensed Unaudited Statement of Changes in Stockholders’ Deficit for the three and six months ended April 30, 2024, previously filed is as follows:
| Schedule of statement of changes in stockholders’ deficit | ||||||||||||
| Changes in Statement of Stockholders' Deficit for the three months ended April 30, 2024 | As Previously Reported | Adjustment | As Restated | |||||||||
| Beginning Additional Paid-in Capital - Balance at January 31, 2024 | $ | $ | $ | |||||||||
| Beginning Accumulated Deficit - Balance at January 31, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Beginning Total Stockholders’ Deficit - Balance at January 31, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Series A preferred issued pursuant to patent agreement, shares | ( |
) | ||||||||||
| Series A preferred issued pursuant to patent agreement, amount | $ | $ | ( |
) | $ | |||||||
| Net loss for the three months ended April 30, 2024 | $ | $ | $ | |||||||||
| Ending Additional paid in capital - Balance at April 30, 2024 | $ | $ | $ | |||||||||
| Ending Accumulated Deficit - Balance at April 30, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Ending Total Stockholders’ Deficit - Balance at April 30, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Changes in Statement of Stockholders' Deficit for the six months ended April 30, 2024 | As Previously Reported | Adjustment | As Restated | |||||||||
| Beginning Additional Paid-in Capital - Balance at October 31, 2023 | $ | $ | $ | |||||||||
| Beginning Accumulated Deficit - Balance at October 31, 2023 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Beginning Total Stockholders’ Deficit - Balance at October 31, 2023 | $ | ( |
) | ( |
) | ( |
) | |||||
| Series A preferred issued pursuant to patent agreement, shares | ( |
) | ||||||||||
| Series A preferred issued pursuant to patent agreement, amount | $ | $ | ( |
) | $ | |||||||
| Net loss for the six months ended April 30, 2024 | $ | $ | ( |
) | $ | |||||||
| Ending Additional paid in capital - Balance at April 30, 2024 | $ | $ | $ | |||||||||
| Ending Accumulated Deficit - Balance at April 30, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Ending Total Stockholders’ Deficit - Balance at April 30, 2024 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| 11 |
The impact of the restatement on the line items within the previously reported Condensed Unaudited Statement of Cash Flows for the six months ended April 30, 2024, previously filed is as follows:
| Schedule of statement of cash flows | ||||||||||||
| Statement of Cash Flows for the six months ended April 30, 2024 |
As Previously Reported | Adjustment | As Restated | |||||||||
| Cash Flow from Operating Activities | ||||||||||||
| Net loss | $ | ( |
) | $ | $ | ( |
) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
| Depreciation and amortization | $ | $ | $ | |||||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Decrease in due from related party | $ | $ | $ | |||||||||
| Increase in accrued interest receivable | $ | ( |
) | $ | $ | ( |
) | |||||
| Increase/(Decrease) in accounts payable | $ | $ | ( |
) | $ | ( |
) | |||||
| Increase/(Decrease) in accrued interest payable | $ | $ | $ | |||||||||
| Increase in lease vendor payable | $ | $ | $ | |||||||||
| Operating lease ROU assets and lease liabilities, net | $ | $ | $ | |||||||||
| Increase (Decrease) in payroll taxes | $ | ( |
) | $ | $ | ( |
) | |||||
| Net Cash Used in Operating Activities | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Cash Flows from Financing Activities | ||||||||||||
| Proceeds from related party advances | $ | $ | $ | |||||||||
| Proceeds from security deposits | $ | $ | $ | |||||||||
| Proceeds from sale of common stock subscription payable | $ | $ | $ | |||||||||
| Proceeds from sale of common stock | $ | $ | $ | |||||||||
| Net Cash Provided by Financing Activities | $ | $ | $ | |||||||||
| Cash Flows from Investing Activities | ||||||||||||
| Purchase of property and equipment | $ | ( |
) | $ | $ | ( |
) | |||||
| Purchase of long term asset | $ | ( |
) | $ | $ | ( |
) | |||||
| Net Cash Used in Investing Activities | $ | ( |
) | $ | $ | ( |
) | |||||
| Net increase (decrease) in cash | $ | ( |
) | $ | $ | ( |
) | |||||
| Cash at beginning of period | $ | $ | $ | |||||||||
| Cash at end of period | $ | $ | $ | |||||||||
| Supplemental Disclosure for Non-Cash Investing and Financing Activities: | ||||||||||||
| Record right-to-use asset and lease liability per ASC 842 | $ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| 12 |
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company for the three and six months ended April 30, 2025.
Out-of-Period Adjustment
During the three months ended April 30, 2025, the Company
recorded an out-of-period adjustment to write off the full gross amount of a previously capitalized intangible asset related to the
prototype Compact Hydrogen Refueling Station (“CHRS”). The asset was originally recorded at $
Management evaluated the error, both qualitatively and quantitatively,
and concluded that the adjustment was not material to any prior interim or annual period. The Company recorded an expense of $
Use of Estimates
The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The management makes its best estimate of the outcome for these items based on information available when the financial statements are prepared.
Cash and Cash Equivalents
The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. As of April 30, 2025, and October 31, 2024, the Company did not hold any investments that qualify as cash equivalents. Therefore, the cash and cash equivalents line item in the balance sheet solely comprises cash.
The Company maintains its cash balances at financial institutions, which at times may exceed federally insured limits. While the Company monitors the credit quality of its banking institutions, cash balances in excess of Federal Deposit Insurance Corporation (FDIC) insurance limits expose the Company to a certain degree of credit risk in the event of the financial institutions' failure.
The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 requires that the cost of equity instrument awards, issued in exchange for services, including those issued to employees and predominantly to consultants, be measured at the grant-date fair value. The Company does not adhere to a formal stock-based compensation plan; rather, it issues stock awards on a discretionary basis as part of compensation agreements with selected employees and consultants. Compensation for stock-based awards is recognized as a non-cash expense on the statement of operations. The expense associated with these awards is recorded based on the fair value on the date of grant, as determined using a pricing model commensurate with the terms of the award. This cost is recognized over the period during which the award recipient is required to perform services, typically known as the vesting period. The total compensation cost related to vested stock-based awards is recognized after adjusting for estimated forfeitures at the time of vesting. The expense related to stock-based compensation is included within the same income statement lines as cash compensation for the consultants and employees who receive the awards, currently included in general and administrative expenses on the statement of operations as the Company does not allocate compensation costs to Costs of Goods Sold. As of the report date, the Company has not established any plans to issue dividends on stock-based awards. Any tax benefits arising from deductions for these awards are recorded in additional paid-in capital, provided they exceed the cumulative compensation cost recognized.
| 13 |
Income Taxes
Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.
The Company follows the provisions of ASC 740, Income
Taxes, related to accounting for uncertainty in income taxes. ASC 740 prescribes a recognition threshold and measurement process for
uncertain tax positions taken or expected to be taken in a tax return. The Company recognizes the financial statement effects of a tax
position when it is more likely than not that, based on technical merits, the position will be sustained upon examination by the relevant
taxing authorities. The Company had
Revenue Recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.
In certain arrangements where the Company facilitates the provision of goods or services provided by a third party, and does not take control of those goods or services, revenue is recognized on a net basis, limited to the margin or fee earned, consistent with the Company’s role as an agent under ASC 606-10-55-36 through 55-40.
During the three months ended April 30, 2025, the
Company recognized $
Basic loss per common share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding for each period. Diluted loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding plus the dilutive effect of shares issuable as common stock equivalents. As the Company is currently presenting net losses the weighted-average number of common shares outstanding excludes potential common stock equivalents because their inclusion would be anti-dilutive.
Property and Equipment
Property and equipment are carried at cost and, less accumulated depreciation. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in the statement of operations in the year of disposal. The Company examines the possibility of decreases in the value of property and equipment when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
The Company’s property and equipment consists of specialized hydrogen equipment, related processing systems, and vehicles. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Small equipment is depreciated over 3 years, vehicles are depreciated over 4 years, and large equipment is depreciated over 7 years.
| Schedule of estimated useful lives | ||
| Useful life | ||
| Small equipment | ||
| Large equipment | ||
| Vehicles |
| 14 |
Impairment of Long-Lived Assets
The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. To determine recoverability of a long-lived asset, management evaluates whether the estimated future undiscounted net cash flows from the asset are less than its carrying amount. If impairment is indicated, the long-lived asset would be written down to fair value. Fair value is determined by an evaluation of available price information at which assets could be bought or sold, including quoted market prices, if available, or the present value of the estimated future cash flows based on reasonable and supportable assumptions.
Leases
The Company accounts for leases in accordance with ASC 842, Leases (“ASC 842”). At contract inception, the Company determines if an arrangement is or contains a lease. Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability. A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease. Leases with an initial expected term of 12 months or less are not recorded in the Balance Sheet and the related lease expense is recognized on a straight-line basis over the lease term.
Fair value of financial instruments
The Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities are carried at cost, which approximates their fair value, due to the relatively short maturity of these instruments.
The Company’s convertible promissory note issued on April 7, 2025, is classified as a liability and measured at fair value on a recurring basis in accordance with ASC 480, Distinguishing Liabilities from Equity, as the instrument requires settlement in a variable number of shares for a fixed monetary amount. The fair value of the convertible note was determined based on the conversion terms and observable market price of the Company’s common stock.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
| · | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
| · | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
| · | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
| 15 |
Assets and liabilities measured at fair value on a recurring basis as of April 30, 2025 were as follows:
| Schedule of fair value of assets and liabilities | ||||||||||||||||
| Total | (Level 1) | (Level 2) | (Level 3) | |||||||||||||
| Assets | $ | $ | $ | $ | ||||||||||||
| Total assets | $ | $ | $ | $ | ||||||||||||
| Liabilities | ||||||||||||||||
| Convertible note payable | ||||||||||||||||
| Total liabilities | $ | $ | $ | $ |
NOTE 4 – GOING CONCERN
On April 30, 2025, we had an accumulated deficit of
$
Based on the above factors, substantial doubt exists about our ability to continue as a going concern for one year from the issuance of these financial statements.
The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
NOTE 5 – PROPERTY AND EQUIPMENT
Property and equipment consisted of the following:
| Schedule of property and equipment | ||||||||
|
April 30, 2025 |
October 31, 2024 | |||||||
| Vehicles | $ | $ | ||||||
| Small equipment | ||||||||
| Large equipment | ||||||||
| Property and Equipment, Gross | $ | $ | ||||||
| Less: Accumulated depreciation | ( |
( |
||||||
| Property and Equipment, Net | $ | $ | ||||||
Depreciation
expenses for the six months ended April 30, 2025 and 2024 were $
NOTE 6 – LEASES
Operating leases
The Company has an operating lease agreement for office space in Murrieta, California, expiring on November 30, 2026.
The Company determined the above office space leases and related extensions are classified as operating leases under ASC 842. Therefore, the Company recognized operating lease liabilities with corresponding Right-Of-Use ("ROU") assets based on the present value of the minimum rental payments of such leases.
| 16 |
As the Company’s leases do not provide an implicit interest
rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s
estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay
to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach
based on information available at the commencement date of the lease. As of April 30, 2025, the ROU asset was $
Remaining lease term as of April 30, 2025:
| Schedule of remaining lease term | ||||||
| Year | Operating Lease Payment | |||||
| 2025 | $ | |||||
| 2026 and above | $ | |||||
| Total Payments | $ | |||||
NOTE 7 – COMMON STOCK
The Company is authorized to issue shares of common stock, par value $.
Stock Issued
During the quarter ended January 31, 2024, the Company
issued shares of common stock for $
During the quarter ended April 30, 2024, the Company
issued shares of common stock for $
During the quarter ended
January 31, 2025, the Company entered into a Stock Subscription Agreement with accredited investors (under Rule 506 (b) of Regulation
D under the Securities Act of 1933, as amended). Whereby the Company privately sold a total of shares of its common stock for an
aggregate cash purchase price of $
During the quarter
ended January 31, 2025, the Company's Board of Directors granted approval for the issuance of shares of our common stock valued
at $
During the
quarter ended April 30, 2025, the Company entered into Stock Subscription Agreements with accredited investors (under Rule 506(b) of Regulation
D under the Securities Act of 1933, as amended). Whereby the Company privately sold a total of shares of its common stock, for
a cash purchase price of $
Stock Receivable
As of April 30, 2025 and October 31, 2024, the Company
issued shares of common stock under Regulation A offering to various shareholders that have not yet paid for shares; therefore,
$
| 17 |
Stock Payable
As of April 30, 2025, the Company sold shares
of common stock under its Regulation A offering to various shareholders that have not yet been issued by the transfer agent; therefore,
$
NOTE 8 – PREFERRED STOCK
The Company is authorized to issue shares of preferred stock, par value $.
Series A Preferred Stock
The Company is authorized to issue shares of Series A preferred stock, par value $.
On January 24, 2023, the
Company issued shares of its Series A Preferred Stock to Donald Owens, the Company’s Chief Executive Officer (CEO) and
Chairman, valued at $
As of April 30, 2025, and October 31, 2024, the Company had and shares of Series A preferred stock issued and outstanding, respectively.
Series B Preferred Stock
The Company is authorized to issue shares of Series B preferred stock, par value $.
On January 2, 2025, the Company entered into a Share Exchange Agreement with the CEO. Pursuant to the agreement, the CEO exchanged shares of the Company’s common stock for shares of Series B Preferred Stock. On January 9, 2025, shares of common stock held by Donald Owens were cancelled, and shares of Series B Preferred Stock were issued to Donald Owens.
On January 2, 2025, the Company entered into a Share Exchange Agreement with HNO Green Fuels, Inc. (“HNO Green Fuels), a related party. Pursuant to the agreement, HNO Green Fuels exchanged shares of the Company’s common stock for shares of Series B Preferred Stock. On January 9, 2025, shares of common stock held by HNO Green Fuels, Inc. were cancelled, and shares of Series B Preferred Stock were issued to HNO Green Fuels, Inc.
As of April 30, 2025, and October 31, 2024, the Company had and shares of Series B preferred stock issued and outstanding, respectively.
NOTE 9 – RELATED PARTY TRANSACTIONS
Notes Payable, Related Party
On December 1, 2021, the Company issued a note payable
in the amount of $
On May 31, 2022, the Company issued a note payable
in the amount of $
On September 29, 2022, the Company issued a note payable
in the amount of $
On October 20, 2022, the Company issued a note payable
in the amount of $
On March 1, 2023, the Company issued a note payable
in the amount of $
| 18 |
On March 8, 2023, the Company issued a note payable
in the amount of $
On March 23, 2023, the Company issued a note payable
in the amount of $
On April 3, 2023, the Company issued a note
payable in the amount of $
On April 13, 2023, the Company issued a note payable
in the amount of $
On April 17, 2023, the Company issued a note payable
in the amount of $
As of April 30, 2025 and October 31, 2024, these current
and long-term notes payable had an aggregate outstanding balance of $
As of April 30, 2025 and October 31, 2024, the Company
has recorded $
Advances from Related Party
During the year ended October 31, 2024, the Company’s
CEO, advanced $
During the year ended October 31, 2024, HNO Green
Fuels advanced $
During the three months ended January 31, 2025, the
Company’s CEO, advanced $
During the three months ended January 31, 2025, HNO
Green Fuels, advanced $
During the three months ended April 30, 2025, the
Company repaid $
During the three months ended April 30, 2025, HNO
Green Fuels advanced an additional $
As of April 30, 2025 and October 31, 2024, related
party advances had an outstanding balance of $
| 19 |
NOTE 10 – CONVERTIBLE PROMISSORY NOTE
On April
7, 2025, the Company entered into a Legal Services Agreement with Newlan Law Firm, PLLC, pursuant to which the Company issued a $
On the issuance
date, April 7, 2025, the Company determined the fair value of the note to be $
As of April
30, 2025, the Company would have accrued $
Following is the maturity schedule for the Company’s convertible notes payable as of April 30, 2025:
| Schedule of maturity convertible notes payable | ||
| Fiscal year ended October 31, | Amount Due | |
| 2025 | $ | |
| 2026 | $ | |
NOTE 11 – TERMINATION OF PATENT AGREEMENT
Patent Purchase Agreement
On January 24, 2023, the
Company entered into a Patent Purchase Agreement with the Company’s CEO, to acquire several patents related to hydrogen supplemental
systems for on-demand hydrogen generation for internal combustion engines and a method and apparatus for increasing combustion efficiency
and reducing particulate matter emissions in jet engines. In exchange for these patents, the Company issued shares of its Series
A Preferred Stock to Mr. Owens, valued at $
Termination of Patent Purchase Agreement
On March 13, 2025, the Company and Donald Owens mutually agreed to terminate the Patent Purchase Agreement as of January 24, 2023. As part of the termination, the patents were returned to Mr. Owens, and the shares of Series A Preferred Stock were canceled. See Note 2 – Correction of Previously Issued Financial Statements. A copy of the Termination Agreement was attached to the Company’s Annual Report on Form 10-K as Exhibit 10.27.
NOTE 12 – SUBSEQUENT EVENTS
Subsequent events have been evaluated through June 20, 2025, which represents the date the financial statements were available to be issued, and no events, other than discussed below have occurred through that date that would impact the financial statements.
Common Stock Issued
The
Company entered into a Stock Subscription Agreement with an accredited investors (under Rule 506(b) of Regulation D under the Securities
Act of 1933, as amended), whereby the Company privately sold a total of shares of its common stock, $ par value per
share (“common stock”), for a cash purchase price of $
| 20 |
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
HNO International, Inc. focuses on systems engineering design, integration, and product development to generate green hydrogen-based clean energy solutions to help businesses and communities decarbonize in the near term.
HNO stands for Hydrogen and Oxygen and our experienced management team has over 14 years of expertise in the green hydrogen production industry.
HNO International provides green hydrogen systems engineering design, integration, and products to multiple markets, which include:
(i) the zero-emission vehicle and mobile equipment market consisting of hydrogen fuel cell electric passenger vehicles, material handling equipment such as forklifts and airport ground support equipment, as well as the medium and heavy-duty truck market;
(ii) the current and emerging hydrogen gas markets encompassing ammonia, fertilizer, steel, mining, electronics, semiconductors, and fuel cell electric vehicles;
(iii) and the gasoline and diesel engine emissions and maintenance reduction product and services market;
(iv) decentralized clean power generation through the newly launched EcoFlare Power division, which captures and converts flared natural gas into electricity and hydrogen for data centers, Bitcoin mining, and industrial use; and
(v) distributed hydrogen infrastructure through the newly introduced HyGrid™ intelligent microgrid system, a solar-hydrogen hybrid
platform enabling off-grid hydrogen production, storage, and refueling.
Results of Operations
For the three months ended April 30, 2025 and 2024
Revenue
For the three months ended April 30, 2025 and 2024, the Company recognized revenue of $43,708 and $0, respectively. Revenue in the current period was generated from the facilitation of the delivery of hydrogen equipment and related integration support. The Company concluded that it acted as an agent with respect to the equipment component of the arrangement, as it did not take control of the goods and the third-party supplier shipped directly to the customer. As a result, revenue was recognized on a net basis, limited to the Company’s retained margin.
Cost of Goods Sold
Cost of Goods Sold consists of direct expenses related to hydrogen engineering services and combustion solution projects, including materials, subcontracted labor, and other project-specific implementation costs. For the three months ended April 30, 2025 and 2024, total cost of sales was $0 and $0, respectively. The Company acted as an agent in facilitating delivery of certain hydrogen refueling equipment during the 2025 period and did not generate separate cost of goods sold.
Gross Profit
For the three months ended April 30, 2025 and 2024, gross profit was $43,708 and $0, respectively. The increase reflects revenue generated from the facilitation of the delivery of hydrogen equipment and integration support services. As the Company was acting as an agent with respect to the equipment delivered by a third-party vendor, no cost of goods sold was recognized, and gross profit equaled the margin retained.
| 21 |
Operating Expenses
General and administrative expenses were $314,323 for the three months ended April 30, 2025, compared to $526,635 during the same period in 2024, a decrease of $212,312. The decrease was due to reduced professional fees, lower consultant costs, and a general reduction in administrative overhead.
Depreciation and amortization expense increased by $14,908, totaling $57,539 for the three months ended April 30, 2025, compared to $42,631 for the three months ended April 30, 2024, due to depreciation associated with additional property and equipment acquired during the period.
Advertising and marketing expenses were $14,810 for the three months ended April 30, 2025, compared to $0 for the same period in 2024. The increase reflects expanded outreach efforts supporting the Company’s hydrogen engineering and combustion solutions.
Other Income (Expenses)
Other expenses increased from $1,589 for the three months ended April 30, 2024 to $127,102 for the period ended April 30, 2025, the increase primarily related to $14,985 loss on fair value of convertible note related to the issuance of a convertible note in exchange for legal services and $105,190 loss on the write-off of intangible asset as a result of an out-of-period adjustment due to the incorrect capitalization of costs associated with developed intellectual property.
Net Loss
Net loss for the three months ended April 30, 2025, was $470,066 compared to a net loss of $570,855 during the same period in 2024.
For the six months ended April 30, 2025 and 2024
Revenue
For the six months ended April 30, 2025 and 2024, the Company recognized revenue of $43,708 and $0, respectively. Revenue in the current period was generated from the facilitation of delivery of hydrogen equipment and related integration support. The Company concluded that it acted as an agent with respect to the equipment component of the arrangement, as it did not take control of the goods and the third-party supplier shipped directly to the customer. As a result, revenue was recognized on a net basis, limited to the Company’s retained margin. Cost of Goods Sold
Cost of Goods Sold consists of direct expenses related to hydrogen engineering services and combustion solution projects, including materials, subcontracted labor, and other project-specific implementation costs. For the six months ended April 30, 2025 and 2024, total cost of sales was $0 and $0, respectively. The Company acted as an agent in facilitating delivery of certain hydrogen refueling equipment during the 2025 period and did not generate separate cost of sales.
Gross Profit
For the six months ended April 30, 2025 and 2024, gross profit was $43,708 and $0, respectively. The increase reflects revenue generated from the facilitation of delivery of hydrogen equipment and integration support services. As the Company was acting as an agent with respect to the equipment delivered by a third-party vendor, no cost of goods sold was recognized, and gross profit equaled the margin retained.
Operating Expenses
General and administrative expenses were $881,930 for the six months ended April 30, 2025, compared to $990,641 during the same period in 2024, a decrease of $108,711. The current period included $265,502 of share-based compensation expense. No share-based compensation was recorded during the same period in 2024. Excluding share-based compensation, general and administrative expenses decreased by $374,213, primarily due to reduced professional fees, lower consultant costs, and a general reduction in administrative overhead.
Depreciation and amortization expense increased by $32,921 to $111,988 for the six months ended April 30, 2025, compared to $79,067 for the same period in 2024, reflecting depreciation on additions to property and equipment.
Advertising and marketing expenses were $20,160 for the six months ended April 30, 2025, compared to $0 for the same period in 2024. The increase reflects the Company’s expanded outreach and promotional activities supporting its hydrogen engineering and combustion solutions offerings.
Other Income (Expenses)
Other expenses increased from $8,220 for the six months ended April 30, 2024 to $134,034 for the period ended April 30, 2025, the increase primarily related to $14,985 loss on fair value of convertible note related to the issuance of a convertible note in exchange for legal services and $105,190 loss on the write-off of intangible asset as a result of an out-of-period adjustment due to the incorrect capitalization of costs associated with developed intellectual property.
| 22 |
Net Loss
Net loss for the six months ended April 30, 2025, was $1,104,404 compared to a net loss of $1,077,928 during the same period in 2024.
Forward-Looking Considerations
The Company recognizes the possibility of future increases in labor or material costs. Factors such as evolving market conditions, potential inflation, and global economic dynamics are considered. We are actively monitoring these aspects to anticipate and navigate any forthcoming rises in labor or material expenses.
Cost-to-Revenue - The Company is assessing alterations in the relationship between cost of sales and revenue. We are examining the factors influencing these changes, including shifts in prices and fluctuations in the volume of services sold. Understanding the impact of these elements is crucial for maintaining a balanced and effective cost-to-revenue structure.
Liquidity and Capital Resources
We incurred a net loss for the three months ended April 30, 2025 of $470,066 and had an accumulated deficit of $45,430,730 at April 30, 2025. At April 30, 2025, we had a cash balance of $72,614, compared to a cash balance of $20,255 at October 31, 2024. At April 30, 2025, the working capital deficit was $2,627,780, compared to a working capital deficit of $1,969,965 at October 31, 2024. Our existing and available capital resources are not expected to be sufficient to satisfy our funding requirements through one year from the date of this filing in the absence of share issuances or other sources of financing.
We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. We have raised capital through sales of common stock and debt securities.
The effect of existing or probable government regulations on our business is not known at this time. Due to the nature of our business, it is anticipated that there may be increasing government regulation that may cause us to have to take serious corrective actions or make changes to the business plan.
There are no external sources of liquidity available to the Company at this time. The Company will need to raise additional capital through equity financings or other means in order to continue operations and meet its obligations. Failure to obtain additional funding could have a material adverse effect on our financial condition and the results of operations.
Cash Flow
For the Six Months Ended April 30, 2025 and 2024
The following table summarizes our cash flows for the periods indicated below:
For the Six Months Ended April 30, 2025 | For the Six Months Ended April 30, 2024 | |||||||
| Cash Used in Operating Activities | $ | (671,197 | ) | $ | (953,923 | ) | ||
| Cash Provided by Financing Activities | 901,500 | 1,069,735 | ||||||
| Net cash used in investing activities | $ | (177,943 | ) | $ | (273,512 | ) | ||
Cash Used in Operating Activities
During the six months ended April 30, 2025, cash used in operating activities amounted to $(671,197), primarily reflecting our net loss of $(1,104,404). This impact was partially offset by non-cash items, including depreciation and amortization of $111,988, $105,190 loss on write-off of an intangible asset, and $59,985 related to a convertible note issued for legal services, including $45,000 recognized as legal expense and a $14,985 fair value adjustment. Changes in working capital included a decrease in accounts payable of $(106,116) and a decrease in accrued payroll of $(8,881), partially offset by a $13,864 increase in accrued interest payable.
During the six months ended April 30, 2024, cash used in operating activities totaled $(953,923), primarily reflecting our net loss of $(1,077,928). This was offset by non-cash charges such as depreciation and amortization amounting to $79,067. Additionally, there was a decrease in due from related party of $56,392 and an increase in accrued interest payable of $13,712 and a decrease in payroll taxes of $14,802, contributing to the overall cash movements during the period.
| 23 |
Cash provided by Financing Activities
During the six months ended April 30, 2025, cash provided by financing activities was $901,500, which consisted of net proceeds from related party advances of $359,000 and proceeds from the sale of common stock of $542,500.
During the six months ended April 30, 2024, cash provided by financing activities was $1,069,735, which consisted of proceeds from related party advances of $710,585, $211,901 from the sale of common stock, $47,249 in proceeds from common stock subscription payable, and a $100,000 refund of a security deposit.
Cash Used in Investing Activities
During the six month ended April 30, 2025, cash used in investing activities was $(177,943), which consisted of the purchase of property.
During the six months ended April 30, 2024, cash used in investing activities was $(273,512), which consisted of the purchase of property and equipment and purchase long-term assets.
Going Concern
The Company’s financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the six months ended April 30, 2025, the Company incurred a net loss of $1,104,404 and used cash in operating activities of $671,197, and on April 30, 2025, had stockholders’ deficit of $1,693,793. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and the classification of liabilities that might result from this uncertainty.
Management is actively seeking additional sources of capital through the sale of equity, advances from related parties, and exploring strategic partnerships. The Company is also focused on attracting suitable investors to support its business plan without relying heavily on existing cash reserves. Additionally, management is implementing cost-saving measures and exploring opportunities to diversify through acquisitions or entering into new markets. However, there can be no assurance that these efforts will result in sufficient funding, and the Company may continue to face substantial uncertainty regarding its ability to achieve profitable operations and sustain its business.
Off-Balance Sheet Arrangements
There are no off-balance sheet arrangements with any party.
Critical Accounting Policies
Our discussion and analysis of results of operations and financial condition are based upon our condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to provisions for uncollectible accounts receivable, inventories, valuation of intangible assets and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
| 24 |
Stock Based-Compensation
The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 requires that the cost of equity instrument awards, issued in exchange for services, including those issued to employees and predominantly to consultants, be measured at the grant-date fair value. The Company does not adhere to a formal stock-based compensation plan; rather, it issues stock awards on a discretionary basis as part of compensation agreements with selected employees and consultants. Compensation for stock-based awards is recognized as a non-cash expense on the statement of operations. The expense associated with these awards is recorded based on the fair value on the date of grant, as determined using a pricing model commensurate with the terms of the award. This cost is recognized over the period during which the award recipient is required to perform services, typically known as the vesting period. The total compensation cost related to vested stock-based awards is recognized after adjusting for estimated forfeitures at the time of vesting. The expense related to stock-based compensation is included within the same income statement lines as cash compensation for the consultants and employees who receive the awards, currently included in general and administrative expenses on the statement of operations as the Company does not allocate compensation costs to Costs of Goods Sold. As of the report date, the Company has not established any plans to issue dividends on stock-based awards. Any tax benefits arising from deductions for these awards are recorded in additional paid-in capital, provided they exceed the cumulative compensation cost recognized.
As of the report date, the Company has not established any plans to issue dividends on stock-based awards.
Fair Value Measurement of Convertible Instruments
The Company evaluates convertible financial instruments in accordance with ASC 480 to determine whether an instrument should be equity classified, or liability classified. The Company issued a $45,000 convertible note in connection with a legal service agreement during the period that allows for a fixed dollar amount to be settled in a a variable number of shares which requires liability classification and was measured at fair value on initial recognition.
On the issuance date, the Company determined the fair value of the note to be $59,985 and recorded the full amount as a liability. The excess of $14,985 over the $45,000 principal amount was recognized as a loss on fair value of the convertible note in the condensed statements of operations.
Fair value is determined in accordance with ASC 820 using available market inputs. Instruments classified as liabilities and measured at fair value are evaluated on a recurring basis, with changes in fair value recognized in the statements of operations.
Revenue Recognition
We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.
In certain arrangements where the Company facilitates the provision of goods or services provided by a third party, and does not take control of those goods or services, revenue is recognized on a net basis, limited to the margin or fee earned, consistent with the Company’s role as an agent under ASC 606-10-55-36 through 55-40.
Proposed Transactions
The Company is not anticipating any transactions.
Changes in Accounting Policies Including Initial Adoption
There were no recent accounting pronouncements that have or will have a material effect on the Company’s financial position or results of operations.
Financial Instruments
The main risks associated with the Company’s financial instruments include credit risk, market risk, and liquidity risk. The Company does not have significant exposure to foreign exchange risk, as all of it operations and transactions are denominated in U.S dollars.
Outstanding Share Data
As of April 30, 2025, the following securities were outstanding:
Common Stock: 80,150,491 shares
Series A Preferred Stock: 5,000,000 shares
Series B Preferred Stock: 360,000 shares
| 25 |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.
ITEM 4. CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.
We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending October 31, 2025, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.
Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.
CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING
There were no changes in our internal control over financial reporting during the quarter ended April 30, 2025 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.
| 26 |
PART II - OTHER INFORMATION
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
The following table includes all unregistered sales of securities made by the Company during the quarter ended April 30, 2025:
| Date | Name | Consideration | Securities | Exemption from Registration |
| 2/18/2025 | John Michael Mosby | Cash | 500,000 | Rule 506 (b) of Regulation D |
| 2/19/2025 | Gordon E. Mosby | Cash | 1,000,000 | Rule 506 (b) of Regulation D |
| 2/26/2025 | Dwight McNeal Ford | Cash | 125,000 | Rule 506 (b) of Regulation D |
| 2/28/2025 | Gordon E. Mosby | Cash | 500,000 | Rule 506 (b) of Regulation D |
| 3/3/2025 | Dwight McNeal Ford | Cash | 75,000 | Rule 506 (b) of Regulation D |
| 3/10/2025 | Ubong E. Ituen | Cash | 1,000,000 | Rule 506 (b) of Regulation D |
| 3/10/2025 | Eno Ituen | Cash | 333,333 | Rule 506 (b) of Regulation D |
| 3/12/2025 | Deborah D. Phillips | Cash | 250,000 | Rule 506 (b) of Regulation D |
| 3/12/2025 | Dwight M. Ford | Cash | 50,000 | Rule 506 (b) of Regulation D |
| 3/14/2025 | Deborah D. Phillips | Cash | 250,000 | Rule 506 (b) of Regulation D |
| 3/17/2025 | Dwight M. Ford | Cash | 50,000 | Rule 506 (b) of Regulation D |
| 3/20/2025 | Ramanathan Gnanadesikan | Cash | 350,000 | Rule 506 (b) of Regulation D |
| 3/26/2025 | Yi Li | Cash | 75,000 | Rule 506 (b) of Regulation D |
No commissions were paid in connection with the sales of securities above. Proceeds from the sale of common stock were applied toward operating capital to support the Company's operations.
ITEM 5. OTHER INFORMATION
Termination of Patent Purchase Agreement
On March 13, 2025, the Company and Donald Owens mutually agreed to terminate the Patent Purchase Agreement as of January 24, 2023. As part of the termination, the patents were returned to Mr. Owens, and the 5,000,000 shares of Series A Preferred Stock were canceled.
Securities Trading Plans of Directors and Executive Officers
None of our directors or executive officers
ITEM 6. EXHIBITS
| Incorporated by reference | ||||||
| Exhibit | Exhibit Description | Filed herewith | Form | Period ending | Exhibit | Filing date |
| 31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1* | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2* | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 101.INS | Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document XBRL Instance Document | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Definition | X | ||||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | |||||
* Furnished, not filed.
| 27 |
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
HNO INTERNATIONAL INC.
| |
| June 23, 2025 |
By: /s/ Donald Owens Donald Owens, Chief Executive Officer (Principal Executive Officer) |
|
By: /s/ Hossein Haririnia Hossein Haririnia, Treasurer (Principal Financial and Accounting Officer) |
******
| 28 |
EXHIBIT 31.1
RULE 13a-14(a)/15d-14(a) CERTIFICATION
I, Donald Owens, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended April 30, 2025, of HNO International Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report
is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles,
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
June 23, 2025
/s/ Donald Owens
Donald Owens
Chief Executive Officer
(Principal Executive Officer)
| 1 |
EXHIBIT 31.2
RULE 13a-14(a)/15d-14(a) CERTIFICATION
I, Hossein Haririnia, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the quarter ended April 30, 2025, of HNO International Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made,
not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report
is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles,
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial
reporting.
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or
persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting.
June 23, 2025
/s/ Hossein Haririnia
Hossein Haririnia, Treasurer
(Principal Financial and Accounting Officer)
| 1 |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HNO International Inc. (the “Company”) on Form 10-Q for the quarter ended April 30, 2025, as filed with the Securities and Exchange Commission (the “Report”), I, Donald Owens, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
June 23, 2025
/s/ Donald Owens
Donald Owens
Chief Executive Officer
(Principal Executive Officer)
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been
provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or
its staff upon request.
| 1 |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HNO International Inc. (the “Company”) on Form 10-Q for the quarter ended April 30, 2025, as filed with the Securities and Exchange Commission (the “Report”), I, Hossein Haririnia, Treasurer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
June 23, 2025
/s/ Hossein Haririnia
Hossein Haririnia, Treasurer
(Principal Financial and Accounting Officer)
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been
provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or
its staff upon request.
| 1 |